Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Pediatric Drugs and Vaccines Revenue

1.5 Market Analysis by Type

1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Diphtheria

1.5.3 Influenza

1.5.4 Hepatitis

1.5.5 Pneumococcal Diseases

1.5.6 Meningococcal Diseases

1.5.7 Mumps

1.5.8 Others

1.6 Market by Application

1.6.1 Global Pediatric Drugs and Vaccines Market Share by Application: 2022-2027

1.6.2 Newborn

1.6.3 Infant

1.6.4 Child

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Pediatric Drugs and Vaccines Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Pediatric Drugs and Vaccines Market Players Profiles

3.1 Merck & Co., Inc. (USA)

3.1.1 Merck & Co., Inc. (USA) Company Profile

3.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Specification

3.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Abbott Laboratories (USA)

3.2.1 Abbott Laboratories (USA) Company Profile

3.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Specification

3.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Amgen, Inc. (USA)

3.3.1 Amgen, Inc. (USA) Company Profile

3.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

3.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Eli Lilly and Company (USA)

3.4.1 Eli Lilly and Company (USA) Company Profile

3.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Specification

3.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 F. Hoffmann-La Roche Ltd (Switzerland)

3.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile

3.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Specification

3.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Genentech, Inc. (USA)

3.6.1 Genentech, Inc. (USA) Company Profile

3.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

3.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 GlaxoSmithKline plc. (UK)

3.7.1 GlaxoSmithKline plc. (UK) Company Profile

3.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Specification

3.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Janssen Biologics B.V. (USA)

3.8.1 Janssen Biologics B.V. (USA) Company Profile

3.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Specification

3.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Actelion Pharmaceuticals

3.9.1 Actelion Pharmaceuticals Company Profile

3.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Specification

3.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 AstraZeneca Plc. (UK)

3.10.1 AstraZeneca Plc. (UK) Company Profile

3.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Specification

3.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Boehringer Ingelheim GmbH (Germany)

3.11.1 Boehringer Ingelheim GmbH (Germany) Company Profile

3.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Specification

3.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Bristol-Myers Squibb Company (USA)

3.12.1 Bristol-Myers Squibb Company (USA) Company Profile

3.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Specification

3.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Allergan, Inc. (USA)

3.13.1 Allergan, Inc. (USA) Company Profile

3.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

3.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Novartis AG (Switzerland)

3.14.1 Novartis AG (Switzerland) Company Profile

3.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Specification

3.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 Novo Nordisk A/S (Denmark)

3.15.1 Novo Nordisk A/S (Denmark) Company Profile

3.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Specification

3.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Pfizer, Inc. (USA)

3.16.1 Pfizer, Inc. (USA) Company Profile

3.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

3.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Sanofi S.A (France)

3.17.1 Sanofi S.A (France) Company Profile

3.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Specification

3.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.18 Shionogi Inc. (USA)

3.18.1 Shionogi Inc. (USA) Company Profile

3.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Specification

3.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.19 Shire Pharmaceuticals Group Plc. (UK)

3.19.1 Shire Pharmaceuticals Group Plc. (UK) Company Profile

3.19.2 Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Product Specification

3.19.3 Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Pediatric Drugs and Vaccines Market Competition by Market Players

4.1 Global Pediatric Drugs and Vaccines Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Market Players (2016-2021)

4.3 Global Pediatric Drugs and Vaccines Average Price by Market Players (2016-2021)

5 Global Pediatric Drugs and Vaccines Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Pediatric Drugs and Vaccines Market Size (2016-2021)

5.1.2 Pediatric Drugs and Vaccines Key Players in North America (2016-2021)

5.1.3 North America Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.1.4 North America Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Pediatric Drugs and Vaccines Market Size (2016-2021)

5.2.2 Pediatric Drugs and Vaccines Key Players in East Asia (2016-2021)

5.2.3 East Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.2.4 East Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Pediatric Drugs and Vaccines Market Size (2016-2021)

5.3.2 Pediatric Drugs and Vaccines Key Players in Europe (2016-2021)

5.3.3 Europe Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.3.4 Europe Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Pediatric Drugs and Vaccines Market Size (2016-2021)

5.4.2 Pediatric Drugs and Vaccines Key Players in South Asia (2016-2021)

5.4.3 South Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.4.4 South Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Pediatric Drugs and Vaccines Market Size (2016-2021)

5.5.2 Pediatric Drugs and Vaccines Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.5.4 Southeast Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Pediatric Drugs and Vaccines Market Size (2016-2021)

5.6.2 Pediatric Drugs and Vaccines Key Players in Middle East (2016-2021)

5.6.3 Middle East Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.6.4 Middle East Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Pediatric Drugs and Vaccines Market Size (2016-2021)

5.7.2 Pediatric Drugs and Vaccines Key Players in Africa (2016-2021)

5.7.3 Africa Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.7.4 Africa Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Pediatric Drugs and Vaccines Market Size (2016-2021)

5.8.2 Pediatric Drugs and Vaccines Key Players in Oceania (2016-2021)

5.8.3 Oceania Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.8.4 Oceania Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Pediatric Drugs and Vaccines Market Size (2016-2021)

5.9.2 Pediatric Drugs and Vaccines Key Players in South America (2016-2021)

5.9.3 South America Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.9.4 South America Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Pediatric Drugs and Vaccines Market Size (2016-2021)

5.10.2 Pediatric Drugs and Vaccines Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Pediatric Drugs and Vaccines Market Size by Type (2016-2021)

5.10.4 Rest of the World Pediatric Drugs and Vaccines Market Size by Application (2016-2021)

6 Global Pediatric Drugs and Vaccines Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Pediatric Drugs and Vaccines Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Pediatric Drugs and Vaccines Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Pediatric Drugs and Vaccines Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Pediatric Drugs and Vaccines Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Pediatric Drugs and Vaccines Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Pediatric Drugs and Vaccines Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Pediatric Drugs and Vaccines Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Pediatric Drugs and Vaccines Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Pediatric Drugs and Vaccines Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Pediatric Drugs and Vaccines Consumption by Countries

7 Global Pediatric Drugs and Vaccines Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Pediatric Drugs and Vaccines (2022-2027)

7.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines (2022-2027)

7.3 Global Forecasted Price of Pediatric Drugs and Vaccines (2022-2027)

7.4 Global Forecasted Production of Pediatric Drugs and Vaccines by Region (2022-2027)

7.4.1 North America Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.3 Europe Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.7 Africa Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.9 South America Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Pediatric Drugs and Vaccines by Application (2022-2027)

8 Global Pediatric Drugs and Vaccines Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.2 East Asia Market Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.3 Europe Market Forecasted Consumption of Pediatric Drugs and Vaccines by Countriy

8.4 South Asia Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.5 Southeast Asia Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.6 Middle East Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.7 Africa Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.8 Oceania Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.9 South America Forecasted Consumption of Pediatric Drugs and Vaccines by Country

8.10 Rest of the world Forecasted Consumption of Pediatric Drugs and Vaccines by Country

9 Global Pediatric Drugs and Vaccines Sales by Type (2016-2027)

9.1 Global Pediatric Drugs and Vaccines Historic Market Size by Type (2016-2021)

9.2 Global Pediatric Drugs and Vaccines Forecasted Market Size by Type (2022-2027)

10 Global Pediatric Drugs and Vaccines Consumption by Application (2016-2027)

10.1 Global Pediatric Drugs and Vaccines Historic Market Size by Application (2016-2021)

10.2 Global Pediatric Drugs and Vaccines Forecasted Market Size by Application (2022-2027)

11 Global Pediatric Drugs and Vaccines Manufacturing Cost Analysis

11.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines

12 Global Pediatric Drugs and Vaccines Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Pediatric Drugs and Vaccines Distributors List

12.3 Pediatric Drugs and Vaccines Customers

12.4 Pediatric Drugs and Vaccines Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Pediatric Drugs and Vaccines Revenue (US$ Million) 2016-2021

Table 6. Global Pediatric Drugs and Vaccines Market Size by Type (US$ Million): 2022-2027

Table 7. Diphtheria Features

Table 8. Influenza Features

Table 9. Hepatitis Features

Table 10. Pneumococcal Diseases Features

Table 11. Meningococcal Diseases Features

Table 12. Mumps Features

Table 13. Others Features

Table 16. Global Pediatric Drugs and Vaccines Market Size by Application (US$ Million): 2022-2027

Table 17. Newborn Case Studies

Table 18. Infant Case Studies

Table 19. Child Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Pediatric Drugs and Vaccines Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Pediatric Drugs and Vaccines Market Growth Strategy

Table 46. Pediatric Drugs and Vaccines SWOT Analysis

Table 47. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Specification

Table 48. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Specification

Table 50. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

Table 52. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Specification

Table 54. Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Specification

Table 56. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

Table 58. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Specification

Table 60. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Specification

Table 62. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Specification

Table 64. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Specification

Table 66. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Specification

Table 68. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Specification

Table 70. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

Table 72. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Specification

Table 74. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Specification

Table 76. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 77. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Specification

Table 78. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 79. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Specification

Table 80. Sanofi S.A (France) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 81. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Specification

Table 82. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 83. Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Product Specification

Table 84. Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Pediatric Drugs and Vaccines Production Capacity by Market Players

Table 148. Global Pediatric Drugs and Vaccines Production by Market Players (2016-2021)

Table 149. Global Pediatric Drugs and Vaccines Production Market Share by Market Players (2016-2021)

Table 150. Global Pediatric Drugs and Vaccines Revenue by Market Players (2016-2021)

Table 151. Global Pediatric Drugs and Vaccines Revenue Share by Market Players (2016-2021)

Table 152. Global Market Pediatric Drugs and Vaccines Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 155. North America Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 157. North America Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 159. East Asia Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 162. East Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 164. East Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 166. Europe Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 169. Europe Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 171. Europe Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 173. South Asia Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 176. South Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 178. South Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 180. Southeast Asia Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 183. Southeast Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 185. Southeast Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 187. Middle East Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 190. Middle East Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 192. Middle East Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 194. Africa Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 197. Africa Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 199. Africa Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 201. Oceania Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 204. Oceania Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 206. Oceania Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 208. South America Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 211. South America Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 213. South America Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 215. Rest of the World Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Pediatric Drugs and Vaccines Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Pediatric Drugs and Vaccines Market Share (2016-2021)

Table 218. Rest of the World Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Pediatric Drugs and Vaccines Market Share by Type (2016-2021)

Table 220. Rest of the World Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Pediatric Drugs and Vaccines Market Share by Application (2016-2021)

Table 222. North America Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 223. East Asia Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 224. Europe Pediatric Drugs and Vaccines Consumption by Region (2016-2021)

Table 225. South Asia Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 226. Southeast Asia Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 227. Middle East Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 228. Africa Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 229. Oceania Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 230. South America Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 231. Rest of the World Pediatric Drugs and Vaccines Consumption by Countries (2016-2021)

Table 232. Global Pediatric Drugs and Vaccines Production Forecast by Region (2022-2027)

Table 233. Global Pediatric Drugs and Vaccines Sales Volume Forecast by Type (2022-2027)

Table 234. Global Pediatric Drugs and Vaccines Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Pediatric Drugs and Vaccines Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Pediatric Drugs and Vaccines Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Pediatric Drugs and Vaccines Sales Price Forecast by Type (2022-2027)

Table 238. Global Pediatric Drugs and Vaccines Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Pediatric Drugs and Vaccines Consumption Value Forecast by Application (2022-2027)

Table 240. North America Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 241. East Asia Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 242. Europe Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 243. South Asia Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 245. Middle East Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 246. Africa Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 247. Oceania Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 248. South America Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Pediatric Drugs and Vaccines Consumption Forecast 2022-2027 by Country

Table 250. Global Pediatric Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)

Table 252. Global Pediatric Drugs and Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2022-2027)

Table 254. Global Pediatric Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)

Table 256. Global Pediatric Drugs and Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2022-2027)

Table 258. Pediatric Drugs and Vaccines Distributors List

Table 259. Pediatric Drugs and Vaccines Customers List





Figure 1. Product Figure

Figure 2. Global Pediatric Drugs and Vaccines Market Share by Type: 2021 VS 2027

Figure 3. Global Pediatric Drugs and Vaccines Market Share by Application: 2021 VS 2027

Figure 4. North America Pediatric Drugs and Vaccines Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 6. North America Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 7. United States Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 8. Canada Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 12. China Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 13. Japan Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 15. Europe Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 16. Europe Pediatric Drugs and Vaccines Consumption Market Share by Region in 2021

Figure 17. Germany Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 19. France Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 20. Italy Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 21. Russia Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 22. Spain Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 25. Poland Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 27. South Asia Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 28. India Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 30. Southeast Asia Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 31. Indonesia Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 37. Middle East Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 38. Turkey Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 40. Iran Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 42. Africa Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 43. Africa Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 44. Nigeria Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 47. Oceania Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 48. Australia Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 49. South America Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 50. South America Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 51. Brazil Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Pediatric Drugs and Vaccines Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Pediatric Drugs and Vaccines Consumption and Growth Rate

Figure 54. Rest of the World Pediatric Drugs and Vaccines Consumption Market Share by Countries in 2021

Figure 55. Global Pediatric Drugs and Vaccines Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Pediatric Drugs and Vaccines Price and Trend Forecast (2022-2027)

Figure 58. North America Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 59. North America Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 75. South America Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Pediatric Drugs and Vaccines Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 79. East Asia Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 80. Europe Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 81. South Asia Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 82. Southeast Asia Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 83. Middle East Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 84. Africa Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 85. Oceania Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 86. South America Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 87. Rest of the world Pediatric Drugs and Vaccines Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Pediatric Drugs and Vaccines

Figure 89. Manufacturing Process Analysis of Pediatric Drugs and Vaccines

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Pediatric Drugs and Vaccines Supply Chain Analysis